Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Calcipotriol 50micrograms/g ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol 50micrograms/mL scalp solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing calcipotriol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcipotriene hydrate 0.005% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriene 0.005% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriene 0.005% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone+calcipotriol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Calcipotriol adverse reaction |
Causative agent (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to calcipotriol |
Causative agent (attribute) |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriene 0.005%/betamethasone 0.064% topical suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol 50 microgram/mL cutaneous foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to calcipotriol |
Causative agent (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcipotriol monohydrate |
Is a |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol hydrate |
Is a |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol monohydrate |
Is modification of (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Calcipotriol 50micrograms/g ointment (substance) |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcipotriol 50micrograms/g ointment (substance) |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing calcipotriol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone and calcipotriol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only calcipotriol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only calcipotriol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
False |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcipotriol 50 microgram/mL cutaneous foam |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcipotriol 50 microgram/mL cutaneous foam |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Betamethasone- and calcipotriol-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Calcipotriol anhydrous |
Is modification of (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Calcipotriol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |